Resistance emergence to zidovudine (ZDV) and lamivudine (3TC(TM)) in HIV-1-infected patients in an ongoing open label trial

被引：0
|
作者：
Rusconi, S [1 ]
dePasquale, MP [1 ]
Milazzo, L [1 ]
Moscatelli, G [1 ]
Kurtagic, S [1 ]
dArminioMonforte, A [1 ]
Galli, M [1 ]
机构：
[1] UNIV MILAN,LUIGI SACCO HOSP,INFECT DIS UNIT,I-20122 MILAN,ITALY
来源：
AIDS | 1996年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：P6 / P6
页数：1
相关论文
共 50 条
  • [41] Cost-efectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-Infected patients
    Sanchez-de la Rosa, Rainel
    Herrera, Luis
    Moreno, Santiago
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (02) : 372 - 381
  • [42] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    R. Palacios
    I. A. Pérez-Hernández
    M. A. Martínez
    M. L. Mayorga
    C. M. González-Domenech
    M. Omar
    J. Olalla
    A. Romero
    J. M. Romero
    I. Pérez-Camacho
    J. Hernández-Quero
    J. Santos
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 815 - 819
  • [43] Rapid onset of M184V mutation and phenotypic resistance to stavudine in zidovudine pre-treated HIV-1-infected individuals receiving the therapeutic regimens zidovudine plus lamivudine or stavudine plus lamivudine
    Rusconi, S
    Milazzo, L
    Testa, L
    Catamancio, SL
    Galazzi, M
    Kurtagic, S
    Citterio, P
    Gianotto, M
    Adorni, F
    d'Arminio-Monforte, A
    Galli, M
    Moroni, M
    [J]. AIDS, 1998, 12 : S23 - S23
  • [44] Clinical and survival benefit of 3TC(TM) in combination with zidovudine-containing regimens in HIV-1 infection: Interim results of the Caesar study
    Katlama, C
    [J]. AIDS, 1996, 10 : SS21 - SS21
  • [45] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    Palacios, R.
    Perez-Hernandez, I. A.
    Martinez, M. A.
    Mayorga, M. L.
    Gonzalez-Domenech, C. M.
    Omar, M.
    Olalla, J.
    Romero, A.
    Romero, J. M.
    Perez-Camacho, I.
    Hernandez-Quero, J.
    Santos, J.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (05) : 815 - 819
  • [46] Hepatitis B Virus Drug Resistance in HIV-1-Infected Patients Taking Lamivudine-Containing Antiretroviral Therapy
    Wongprasit, Pawinee
    Manosuthi, Weerawat
    Kiertiburanakul, Sasisopin
    Sungkanuparph, Somnuek
    [J]. AIDS PATIENT CARE AND STDS, 2010, 24 (04) : 205 - 209
  • [47] Doravirine plus lamivudine (DOR/3TC) two-drug regimen as a maintenance antiretroviral therapy in controlled HIV-infected patients
    Perfezou, P.
    Hall, N.
    Duthe, J.
    Abdi, B.
    Seang, S.
    Marcelin, A.
    Katlama, C.
    Palich, R.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 94 - 94
  • [48] Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy)
    Casado, A
    Badia, X
    Consiglio, E
    Ferrer, E
    González, A
    Pedrol, E
    Gatell, JM
    Azuaje, C
    Llibre, JM
    Aranda, M
    Barrufet, P
    Martínez-Lacasa, J
    Podzamczer, D
    [J]. HIV CLINICAL TRIALS, 2004, 5 (03): : 132 - 139
  • [49] Switch from Enfuvirtide to Raltegravir in Virologically Suppressed Multidrug-Resistant HIV-1-Infected Patients: A Randomized Open-Label Trial
    De Castro, Nathalie
    Braun, Josephine
    Charreau, Isabelle
    Pialoux, Gilles
    Cotte, Laurent
    Katlama, Christine
    Raffi, Francois
    Weiss, Laurence
    Meynard, Jean-Luc
    Yazdanpanah, Yazdan
    Delaugerre, Constance
    Madelaine-Chambrin, Isabelle
    Aboulker, Jean-Pierre
    Molina, Jean-Michel
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : 1259 - 1267
  • [50] Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine
    Milazzo, L
    Rusconi, S
    Testa, L
    La Seta-Catamancio, S
    Galazzi, M
    Kurtagic, S
    Citterio, P
    Gianotto, M
    Grassini, A
    Adorni, F
    d'Arminio-Monforte, A
    Galli, M
    Moroni, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (01): : 101 - 103
12345